Recruiting

Autoimmune Liver Disease

Sponsor:

Children's Hospital Medical Center, Cincinnati

Code:

NCT05750498

Conditions

Autoimmune Hepatitis

Primary Sclerosing Cholangitis

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

No interventions

Study Details

Brief summary:

The Autoimmune Liver disease Network for Kids (A-LiNK) is a multi-institutional group with the mission to deliver the best care to kids with pediatric autoimmune liver disease (AILD).

This study will establish a shared clinical registry and a learning health network for the participating sites focusing on collecting and transmitting clinical measurement data, information about processes, and participation in an improvement collaborative.

Pediatric Autoimmune Hepatitis (AIH) and Primary Sclerosing Cholangitis (PSC), represent a spectrum of AILD which present unique diagnostic and therapeutic challenges.A lack of accepted guidelines for disease monitoring or symptom management results in wide treatment variation with liver transplants indicated in refractory, progressive disease.

The aims of A-LiNK are to:

1.) Create a learning health network focused on patient-centered outcomes research characterized by transparent sharing among centers, common priorities, and feasible plans for implementing new practices; 2) shift from traditional investigator-driven study to a patient and family-centered approach, and 3.) improve clinical outcomes and quality of life for pediatric AILD patients.

Conditions

Autoimmune Hepatitis

Primary Sclerosing Cholangitis

Study ID

NCT05750498

Start date

Apr 28, 2022

Status verified date

Aug, 2026

Completion date

Jun 30, 2033

Anticipated

Primary completion date

Dec 31, 2032

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Clinical diagnosis of autoimmune hepatitis (AIH)
  • Clinical diagnosis of primary sclerosing cholangitis (PSC)
  • Clinical diagnosis of autoimmune sclerosing cholangitis (ASC)

Exclusion Criteria:

• History of liver transplant

Study Design

Enrollment

800 participants

Anticipated

Interventions and Outcome Measures

Arms

Children and adolescents with Autoimmune Liver Disease

Pediatric patients with a diagnosis of autoimmune hepatitis, or primary sclerosing cholangitis.

Interventions

No interventions

There are no interventions

Primary outcome measure

  • Baseline disease characteristics in the population [ Time Frame: 2034 ]
  • Disease relapse and biochemical remission rates [ Time Frame: 2034 ]
  • Complications of disease [ Time Frame: 2034 ]
  • Side-effects of steroids [ Time Frame: 2034 ]
  • Pediatric Quality of Life Inventory (PedsQL 4.0) Generic Core Scales Short Form 15 [ Time Frame: 2034 ]
  • Racial and ethnic disparities [ Time Frame: 2034 ]

Central Contacts and Locations

Central contacts

Locations

Stanford University

Recruiting

Palo Alto, California, United States, 94304

Contacts

Principal Investigator:

Leina Alrabadi, MD

Riley Children's Health

Recruiting

Indianapolis, Indiana, United States, 46202

Contacts

Wendy Morlan, RN, BSN

317-274-9601wmorlan@iu.edu

Ann Klipsch, RN

aeye@iu.edu

Principal Investigator:

Kyla Tolliver, MD

St. Louis Children's Hospital

Recruiting

St Louis, Missouri, United States, 63110

Contacts

Principal Investigator:

Sakil S Kulkarni, MD

Cincinnati Children's Hospital Medical Center

Recruiting

Cincinnati, Ohio, United States, 45229

Contacts

Principal Investigator:

Amy E Taylor, MD

Nationwide Children's Hospital

Recruiting

Columbus, Ohio, United States, 43205

Contacts

Principal Investigator:

Alexander Weymann, MD

UPMC Children's Hospital of Pittsburgh

Recruiting

Pittsburgh, Pennsylvania, United States, 15224

Contacts

Laura Mathews, Research Coordinator, BS

4126925811mathewslj3@upmc.edu

Susan Richey, Research Coordinator, RN

4126926337richeys@upmc.edu

Principal Investigator:

James E Squires, MD

UT Southwestern Medical Center

Recruiting

Dallas, Texas, United States, 75390

Contacts

Principal Investigator:

Sindhu Pandurangi, MD

Seattle Children's Hospital

Recruiting

Seattle, Washington, United States, 98105

Contacts

Principal Investigator:

Katelyn M Saarela, DO

More Information

Sponsor

Children's Hospital Medical Center, Cincinnati

Last update posted

Aug 19, 2026

Last verified

Aug, 2026

Keywords

  • Pediatrics
  • Autoimmune Hepatitis
  • Primary Sclerosing Cholangitis
  • Autoimmune Sclerosing Cholangitis
  • Chronic Liver Disease
  • End-stage Liver Disease
  • Clinical Registry
  • Research Registry
  • Quality Improvement
  • Outcomes Research
  • Comparative Effectiveness Research
  • Patient Reported Outcomes
  • Health Services Research

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Children's Hospital Medical Center, Cincinnati on 2026-08-19.